X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12-31 | PRLD | Vaddi Krishna | CEO | P - Purchase | $1.21 | +5,000 | 2,837,033 | 0% | +$6,044 | ||||||
2024-12-30 | PRLD | Vaddi Krishna | CEO | P - Purchase | $1.20 | +10,000 | 2,832,043 | 0% | +$12,000 | ||||||
| M | 2024-12-20 | PRLD | Combs Andrew | Chief Chemistry Officer | P - Purchase | $1.36 | +63,075 | 377,623 | +20% | +$85,538 | |||||
2024-12-19 | PRLD | Lim Bryant David | CLO, Interim CFO, Corp Sec. | P - Purchase | $0.91 | +25,000 | 27,400 | >999% | +$22,638 | ||||||
| M | 2024-12-18 | PRLD | Vaddi Krishna | CEO | P - Purchase | $0.93 | +106,888 | 2,822,043 | +4% | +$99,326 | |||||
| M | 2023-05-24 | PRLD | Vaddi Krishna | CEO | P - Purchase | $5.15 | +1,900 | 2,715,145 | 0% | +$9,790 | |||||
2023-05-24 | PRLD | Lim Bryant David | GC, Corp Sec. | P - Purchase | $5.39 | +2,400 | 2,400 | New | +$12,936 | ||||||
2023-05-23 | PRLD | Chardonnet Laurent | CFO | P - Purchase | $5.50 | +5,000 | 42,165 | +13% | +$27,500 | ||||||
2023-05-23 | PRLD | Vaddi Krishna | CEO | P - Purchase | $5.63 | +11,856 | 2,713,245 | 0% | +$66,749 | ||||||
2023-05-22 | PRLD | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $5.75 | +869,565 | 10,646,056 | +9% | +$4,999,999 | ||||||
2023-05-22 | PRLD | Bonita David P | Dir, 10% | P - Purchase | $5.75 | +869,565 | 10,646,056 | +9% | +$4,999,999 | ||||||
| D | 2023-04-06 | PRLD | Huang Jane | Pres, CMO | S - Sale+OE | $6.12 | -13,280 | 24,220 | -35% | -$81,274 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |